BRCA Gene
BRCA Gene
The BRCA gene is short for breast cancer gene, and it refers to a pair of genes called BRCA1 and BRCA2. These genes play a critical role in the body's ability to suppress the development of tumors, particularly in the breasts and ovaries. Mutations in the BRCA genes significantly increase an individual's risk of developing breast, ovarian, and other cancers.
BRCA gene mutations are inherited, meaning they can be passed down from one generation to the next, impacting not only the individual but also their offspring. Understanding the implications of BRCA gene mutations is vital in assessing cancer risk and developing appropriate prevention and treatment strategies.
What are the BRCA1 and BRCA2 Genes?
The BRCA1 and BRCA2 genes are human genes that produce proteins that suppress the development of tumors. These proteins help repair damaged DNA and play a crucial role in maintaining the stability of the cells' genetic material. When functioning correctly, BRCA1 and BRCA2 genes help prevent uncontrolled cell growth and the development of tumors, particularly in breast and ovarian tissues in women and pancreas and prostate in men.
When the normal function of these genes is disrupted, it leads to an increased risk of these types of cancer.
BRCA Gene Mutations
BRCA gene mutations are alterations or changes in the DNA sequence of the BRCA1 or BRCA2 genes. These mutations disrupt the normal function of the BRCA genes, compromising their ability to suppress tumor growth and repair damaged DNA. As a result, individuals with BRCA gene mutations have an increased risk of developing breast, ovarian, and other cancers compared to those without these mutations.
BRCA1 and BRCA2 are responsible for roughly half of the families with a known genetic predisposition to inherited cancers. The remaining cases of inherited breast cancers are associated with less frequent mutations in other genes.
BRCA gene mutations can be inherited from a parent who carries the mutation or can occur spontaneously during a person's lifetime. The mutated gene can be carried by women or men, and both have a risk of passing the defective gene on to their children.
There are various types of BRCA gene mutations, each of which may have different implications for cancer risk and management. The defective genes are inherited in an autosomal dominant pattern, meaning that a mutation in just one copy of the gene is sufficient to increase cancer risk.
Genetic Testing
Genetic testing for BRCA genes involves analyzing a person's DNA to identify mutations or changes within the BRCA1 and BRCA2 genes. These genes are known to significantly increase the risk of developing breast, ovarian, and other cancers when mutated. Individuals with a family history of these cancers or those who exhibit certain risk factors may opt for BRCA genetic testing.
Results from genetic testing can provide crucial information about an individual's cancer risk, guiding decisions regarding prevention strategies, screening schedules, and treatment options.
Before and after undergoing BRCA genetic testing, individuals are often advised to seek genetic counseling to better understand the implications of their results and to explore potential medical interventions or lifestyle modifications to mitigate the risk of developing cancer.
Interpreting Test Results
Genetic testing reveals whether you have mutations in genes like BRCA1, BRCA2, or others linked to cancer. For individuals with breast cancer—or at significant risk of developing breast cancer—these results assist in determining the appropriate treatment pathway.
There are three possible outcomes to genetic testing:
The test indicates normal findings, suggesting no gene mutations that elevate the risk of breast cancer. This result generally guides treatment toward standard options.
The test identifies a gene mutation that increases the risk of breast cancer and possibly other cancers like ovarian cancer (in women) and prostate cancer (in men). For some breast cancer patients, a positive test result influences surgical decisions and may expand drug therapy choices.
Remember, having a BRCA1 or BRCA2 (BRCA1/2) inherited gene mutation or another inherited gene mutation that increases breast cancer risk doesn’t guarantee you’ll develop breast cancer. Some individuals with an inherited gene mutation never develop breast cancer, and those without such mutations are still at risk. Most women diagnosed with breast cancer don’t have an inherited gene mutation or a family history of breast cancer.
If you have a BRCA1/2 gene mutation, there are specific guidelines for cancer screening. For women, there are also options available to help reduce the risk of breast cancer. It's important to discuss these options with your healthcare provider.
This result is inconclusive but leans towards negativity. It signifies a minor gene alteration requiring further investigation.
A VUS test result isn’t definitive, but most minor gene changes turn out to be normal variants. These variants usually don’t affect the gene’s function, meaning they don’t raise breast cancer risk. VUS results are typically treated similarly to negative results.
VUS results are more common with expanded panel testing than with BRCA1 and 2 genetic testing. Expanded panel testing examines many genes, not just BRCA genes. With more genes in the test, VUS results are more likely.
A VUS test result can be confusing. If you have questions, consult with your doctor or a genetic counselor.
Risk Reduction
Regardless of whether you have a gene mutation that increases breast cancer risk, there are steps you can take to help lower your risk. Learning about a healthy lifestyle and its impact on breast cancer risk is essential.
For individuals with high-risk inherited gene mutations related to breast cancer, knowing about these mutations enables your doctor to recommend personalized screening plans. Women with high-risk gene mutations typically undergo more frequent screening and start at a younger age than those with an average risk of breast cancer.
Options for lowering breast cancer risk include:
- Risk-lowering drugs
- Risk-reducing mastectomy
- Risk-reducing salpingo-oophorectomy
If you have a BRCA inherited gene mutation, it's important to discuss the advantages and disadvantages of these options with your doctor. Contact the Silver Lining BRCA & Breast Reconstruction Center [Link to Contact] for a video call with one of our BRCA specialist surgeons to find out your options for treatment and risk reduction.